Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.848,28
0,89%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Nighthawk Biosciences Inc (NHWK) Nighthawk Biosciences Inc (NHWK) Notizie

NHWK

Nighthawk Biosciences (NHWK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:NHWK
DataOraFonteTitoloSimboloCompagnia
03/05/202422:00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
03/05/202413:18Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
02/05/202414:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/04/202422:52Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NHWKNighthawk Biosciences Inc
19/03/202413:30GlobeNewswire Inc.Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityAMEX:NHWKNighthawk Biosciences Inc
14/03/202413:30GlobeNewswire Inc.Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-ConsortiumAMEX:NHWKNighthawk Biosciences Inc
13/03/202411:17Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]AMEX:NHWKNighthawk Biosciences Inc
12/03/202422:00GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
08/03/202406:20GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
07/03/202422:18GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Proposed Public Offering of Common StockAMEX:NHWKNighthawk Biosciences Inc
07/03/202414:30GlobeNewswire Inc.Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023AMEX:NHWKNighthawk Biosciences Inc
06/02/202414:00GlobeNewswire Inc.NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayAMEX:NHWKNighthawk Biosciences Inc
01/02/202414:00GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerAMEX:NHWKNighthawk Biosciences Inc
30/01/202414:00GlobeNewswire Inc.NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteAMEX:NHWKNighthawk Biosciences Inc
25/01/202414:30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramAMEX:NHWKNighthawk Biosciences Inc
16/01/202414:30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientAMEX:NHWKNighthawk Biosciences Inc
08/01/202414:30GlobeNewswire Inc.NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOAMEX:NHWKNighthawk Biosciences Inc
03/01/202414:30GlobeNewswire Inc.NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityAMEX:NHWKNighthawk Biosciences Inc
21/12/202314:30GlobeNewswire Inc.NightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research UniversityAMEX:NHWKNighthawk Biosciences Inc
19/12/202322:47Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
19/12/202322:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:NHWKNighthawk Biosciences Inc
18/12/202314:30GlobeNewswire Inc.NightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical CompanyAMEX:NHWKNighthawk Biosciences Inc
12/12/202314:30GlobeNewswire Inc.NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core AssetsAMEX:NHWKNighthawk Biosciences Inc
20/11/202322:05GlobeNewswire Inc.NightHawk Biosciences Provides Q3 2023 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
14/08/202322:05GlobeNewswire Inc.NightHawk Biosciences Provides Q2 2023 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
15/05/202322:05GlobeNewswire Inc.NightHawk Biosciences Provides Q1 2023 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
31/03/202322:05GlobeNewswire Inc.NightHawk Biosciences Provides 2022 Year End Business UpdateAMEX:NHWKNighthawk Biosciences Inc
14/11/202222:01GlobeNewswire Inc.NightHawk Biosciences Provides Third Quarter 2022 Business UpdateAMEX:NHWKNighthawk Biosciences Inc
21/10/202214:00GlobeNewswire Inc.Nighthawk Biosciences’ Scorpion Subsidiary Announces Grand Opening of its San Antonio FacilityAMEX:NHWKNighthawk Biosciences Inc
23/08/202213:30GlobeNewswire Inc.NightHawk Biosciences Announces Buildout of Advanced Biosafety Level 2 (BSL-2) LaboratoryAMEX:NHWKNighthawk Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:NHWK

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
TEN
Tenaris
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
CPR
Davide Campari
BIT
TRN
Terna Trasmissione Elett...
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SRG
Snam
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network